Pfizer keeps King tender offer open till January

Pfizer is once again extending its offer to buy King Pharmaceuticals to Jan. 21, saying about 47 percent of King shares have been tendered. Story

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.